97 related articles for article (PubMed ID: 12729068)
1. Pyridinoline cross-links as markers for primary and secondary bone tumors.
Behrens P; Bruns J; Ullrich KP; Açil Y; Gille J
Scand J Clin Lab Invest; 2003; 63(1):37-44. PubMed ID: 12729068
[TBL] [Abstract][Full Text] [Related]
2. Differential enhancement of collagen crosslink excretion in cases of osteosarcoma and chondrosarcoma.
Açil Y; Springer I; Behrens P; Ullrich KP; Hedderich J; Bruns J
J Cancer Res Clin Oncol; 2003 Oct; 129(10):583-8. PubMed ID: 14513370
[TBL] [Abstract][Full Text] [Related]
3. Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods.
Kamel S; Brazier M; Neri V; Picard C; Samson L; Desmet G; Sebert JL
J Bone Miner Res; 1995 Sep; 10(9):1385-92. PubMed ID: 7502711
[TBL] [Abstract][Full Text] [Related]
4. Concentration of collagen cross-links in human dentin bears no relation to the individual age.
Açil Y; Springer IN; Prasse JG; Hedderich J; Jepsen S
Int J Legal Med; 2002 Dec; 116(6):340-3. PubMed ID: 12461641
[TBL] [Abstract][Full Text] [Related]
5. [Reference values of assayable pyridinolines as markers of bone turn-over].
Zolezzi C; Lenzi L; Salizzoni MP; Pizzoferrato A
Minerva Med; 1995; 86(1-2):5-9. PubMed ID: 7753439
[TBL] [Abstract][Full Text] [Related]
6. A new method of monitoring osteomyelitis.
Springer IN; Wiltfang J; Dunsche A; Lier GC; Bartsch M; Warnke PH; Barth EL; Terheyden H; Russo PA; Czech N; Acil Y
Int J Oral Maxillofac Surg; 2007 Jun; 36(6):527-32. PubMed ID: 17418531
[TBL] [Abstract][Full Text] [Related]
7. [The biochemical markers of bone remodeling in cancer patients with skeletal involvement].
Liubimova NV; Bronnikov IIu; Robins SP; Trapeznikova MF; Kushlinskiĭ NE
Vopr Onkol; 2000; 46(3):290-7. PubMed ID: 10976274
[TBL] [Abstract][Full Text] [Related]
8. The course of the urinary DPD-crosslink secretion in metastatic breast cancer--a possibility for response assessment.
Lüftner D; Günther S; Flath B; Müller C; Echteroff K; Mergenthaler HG; Wernecke KD; Possinger K
Anticancer Res; 1999; 19(4A):2537-44. PubMed ID: 10470191
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of collagen degradation markers by sows during postpartum uterine involution.
Belstra BA; Flowers WL; Croom WJ; Degroot J; See MT
Anim Reprod Sci; 2005 Jan; 85(1-2):131-45. PubMed ID: 15556316
[TBL] [Abstract][Full Text] [Related]
10. [Markers of bone tissue resorption in skeleton metastasis].
Liubimova NV; Kushlinskiĭ NE; Robins SP
Biull Eksp Biol Med; 1998 Mar; 125(3):323-8. PubMed ID: 9606556
[No Abstract] [Full Text] [Related]
11. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of urine deoxypyridinoline for detecting bone metastases in breast cancer patients.
Hou MF; Lin SB; Yuan SS; Tsai LY; Tsai SM; Hsieh JS; Huang TJ
Ann Clin Lab Sci; 2003; 33(1):55-61. PubMed ID: 12661898
[TBL] [Abstract][Full Text] [Related]
13. Increased excretion of collagen crosslinks in irradiated patients indicates destruction of collagen.
Niehoff P; Wiltfang J; Springer IN; Weppner N; Kimmig B; Acil Y
Int J Radiat Biol; 2006 Jul; 82(7):503-9. PubMed ID: 16882622
[TBL] [Abstract][Full Text] [Related]
14. Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases.
Walls J; Assiri A; Howell A; Rogers E; Ratcliffe WA; Eastell R; Bundred NJ
Br J Cancer; 1999 Jun; 80(8):1265-70. PubMed ID: 10376982
[TBL] [Abstract][Full Text] [Related]
15. Rapid method for the isolation of the mature collagen cross-links, hydroxylysylpyridinoline and lysylpyridinoline.
Açil Y; Müller PK
J Chromatogr A; 1994 Apr; 664(2):183-8. PubMed ID: 21941695
[TBL] [Abstract][Full Text] [Related]
16. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
17. Serum and urinary metabonomic study of human osteosarcoma.
Zhang Z; Qiu Y; Hua Y; Wang Y; Chen T; Zhao A; Chi Y; Pan L; Hu S; Li J; Yang C; Li G; Sun W; Cai Z; Jia W
J Proteome Res; 2010 Sep; 9(9):4861-8. PubMed ID: 20690664
[TBL] [Abstract][Full Text] [Related]
18. Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP).
Açil Y; Brinckmann J; Notbohm H; Müller PK; Bätge B
Scand J Clin Lab Invest; 1996 May; 56(3):275-83. PubMed ID: 8761532
[TBL] [Abstract][Full Text] [Related]
19. Validation of a high-performance liquid chromatographic assay for lysylpyridinoline in urine: a potential biomarker of bone resorption.
Casserly UM; O'Rorke A; Power MJ; Fottrell PF
Anal Biochem; 1996 Nov; 242(2):255-60. PubMed ID: 8937570
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic determination of 3-hydroxypyridinium derivatives as new markers of bone resorption.
Kamel S; Brazier M; Desmet G; Picard C; Mennecier I; Sebert J
J Chromatogr; 1992 Feb; 574(2):255-60. PubMed ID: 1618957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
